XML 48 R35.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
CAPITAL STOCK (Tables)
12 Months Ended
Mar. 31, 2024
Equity [Abstract]  
SCHEDULE OF OUTSTANDING AND EXERCISABLE STOCK PURCHASE WARRANTS

At March 31, 2024, 2023, and 2022, outstanding and exercisable stock purchase warrants consisted of the following:

   Number of
Shares
  

Weighted

Averaged
Exercise Price

   Weighted
Average Life
Remaining (Years)
 
Outstanding at March 31, 2021   3,607,945   $2.31    3.24 
Granted   200,000    0.01    3.92 
Exercised   (874,190)   1.76    - 
Forfeited or cancelled   -    -    - 
Outstanding at March 31, 2022   2,933,755   $2.32    2.29 
Exercisable at March 31, 2022   2,933,755   $2.32    2.29 

 

   Number of
Shares
  

Weighted

Averaged
Exercise Price

   Weighted
Average Life
Remaining (Years)
 
Outstanding at March 31, 2022   2,933,755   $2.32    2.29 
Granted   150,000    0.01    4.5 
Exercised   (300,003)   0.34    - 
Forfeited or cancelled   (322,806)   2.00    - 
Outstanding at March 31, 2023   2,460,946   $2.46    1.59 
Exercisable at March 31, 2023   2,460,946   $2.46    1.59 

 

   Number of
Shares
  

Weighted

Averaged
Exercise Price

   Weighted
Average Life
Remaining (Years)
 
Outstanding at March 31, 2023   2,460,946   $2.46    1.59 
Exercised   (31,750)   2.40    - 
Forfeited or cancelled   (720,366)   3.19    - 
Outstanding at March 31, 2024   1,708,830   $2.16    1.09 
Exercisable at March 31, 2024   1,708,830   $2.16    1.09 
SCHEDULE OF SHARE BASED COMPENSATION ARRANGEMENTS

Number of Options   400,000 
Option Vesting Period   Up to 3 years 
Per share grant price  $2.08 
Dividend yield   - 
Expected volatility   83.5%
Risk-free interest rate   4.13%
Expected life (years)   5.75 
Weighted average fair value  $1.50